Bookmarks Share Print

Pulmonary Arterial Hypertension Eligibility

Inclusion and Exclusion Criteria

Patients who may be eligible to participate in the trial must meet the following criteria:

  • Written informed consent must be obtained before any assessment is performed
  • Must be a man or woman 18 years of age or older 
  • Must have been diagnosed by their doctor with pulmonary arterial hypertension
  • Must not be pregnant or nursing
  • Must have persistent symptoms due to PAH despite therapy with at least one of the following PAH medications: an endothelin receptor antagonist, a soluble guanylate cyclase stimulator or a phosphodiesterase inhibitor
  • Must not have a history of immunodeficiency diseases, including a positive HIV test result

If the requirements above apply, you may be eligible to participate. If you are interested in participating, please find the nearest study site to discuss next steps. Please remember that only the trial investigator can determine whether a person is eligible to participate and that you can leave the trial at any time for any reason.